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Abstract
UK government seeks the use of Benefits Realisation Management Processes (BRMPs) to direct 
capital investments that are technically complex and must satisfy a diverse range of stakeholder 
needs. Although BRMP frameworks are available, methods to inform them with reliable 
quantifications of stakeholders’ judgements of benefits realisation are currently absent.  
The articulation of benefits in current practice is reviewed to establish the context of benefits 
realisation. Benefit-related healthcare policy is reviewed by desktop survey of government 
publications and NHSScotland business cases. A conceptual framework for benefits 
quantification which characterises benefits realisation using stakeholders’ judgements and 
perceptions of benefit worth is contributed. 
Translation of stakeholder judgements of benefit provision magnitude into indications of benefit 
worth by means of benefit functions is explored and related to BRMP operation. The use of utility 
functions to translate judgements of magnitude into representations of ‘worth’ is found to be an 
appropriate premise for benefit quantification.
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1. 	 Introduction
The notion of “benefits realisation” is prominent in public sector capital investment policy and 
guidance. Investment approval requires a defensible prediction that stakeholders will receive 
sought benefits. Investment performance is evaluated by stakeholders’ views of the extent to 
which these benefits have been realised.  
With the understanding that a ‘benefit’ is a desired change, a broad view of benefits has emerged 
which embraces their often intangible nature.  Investors are increasingly expected to implement 
a “Benefits Realisation Management Process” (BRMP) which, alongside quantitative 
measurement of tangible benefits, gathers stakeholder judgements of intangible benefit delivery. 
A BRMP requires a structured and reliable way of eliciting and documenting stakeholders’ 
evaluations to characterise investment success. In the healthcare sector, a method of 
1
characterising stakeholders’ views must accommodate the evaluation of benefits defined 
variously, from: 
“The creation of a short stay assessment unit, an approach which has been pioneered 
widely in UK hospitals, will facilitate children to be assessed, observed and treated and 
discharged normally within 24 hours.” (NHS Ayrshire & Arran, undated)
to 
“Flexibility and adaptability” (Mitchell et al., 2006). 
Benefit diversity is partly caused by differences between the needs of the healthcare providers 
investing in health services and those creating and operating the buildings housing those 
services. Further diversity arises among innumerable stakeholder subgroups. Stakeholders have 
unique bodies of knowledge, yet must express their views of performance using a common set of 
project benefits. A BRMP must accommodate diverse definitions and judgements of benefits 
gathered across multiple stakeholder groups to evaluate benefits realisation performance 
throughout project delivery.
This paper proposes a Benefits Quantification Method (BQM) to reliably engage stakeholders in 
the quantification of healthcare investment benefits when faced with: diversity in the nature of 
the benefits sought; diversity in the communities of evaluating stakeholders; and the need to 
evaluate intangible benefits using judgement, opinion and preference. The problem is explored 
with reference to UK government policy and the projects of NHS Boards in NHSScotland. 
2.	 The Nature of Healthcare Benefits in Policy and Practices
Benefits can be tangible (such as design metrics and budgetary outcomes) or intangible (such as 
perceptions of attractiveness and feelings of safety). Patients are particularly affected by the 
intangible aspects of buildings and services. Patients are often weak, stressed, and unable to 
control their environment, amplifying the impact of intangible benefits on their well-being. 
Alongside service improvements, healthcare investments are expected to produce buildings that 
promote a desire to get well (DCMS, 2000; van den Berg, 2005), stimulate emotional responses 
(Baker and Lamb, 1992), or improve health outcomes (NHS Estates, 2003; Ulrich et al., 2004). 
Proving the realisation of such intangible benefits is problematic. Despite this, the realisation of 
both benefit types is increasingly considered indicative of project success.
2.1	 The Role of Benefits and Benefit Realisation in Charactering Project Success
Our understanding of project success is evolving. Jugdev and Muller (2005) suggest that 
“success” has broadened to acknowledge the importance of stakeholders’ views. In construction, 
stakeholders have been positioned as arbiters of project success by the Commission for 
Architecture and the Built Environment (Macmillan, 2006), the Design Quality Indicator (Gann et. 
al., 2003) and VALiD (Austin and Thomson, 2005).  
Project success has latterly beet related to benefits (Cooke-Davies, 2007). Reiss et al. (2006) 
suggest that projects perceived as unsuccessful often fail to acknowledge or articulate their role 
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in providing the benefits stakeholders seek. BRMPs address this problem. The Office of 
Government Commerce (OGC, 2003) recommended BRMP use to guide the “realisation” (i.e. 
provision to the stakeholders that seek them) of benefits.  
Several BRMP models have been developed including OGC (2003), Bradley (2006), Reiss et al. 
(2006) and Sapountzis et al. (2009). BRMPs define activities in which benefits delivery 
performance (actual or predicted) is periodically evaluated to gauge project performance and 
inform decisions.  As of writing, however, no means of quantifying benefit provision exists.  
BRMPs require a Benefits Quantification Method (BQM) to characterise benefits realisation at any 
stage in the investment process, from the perspective of the stakeholders to whom those 
benefits will accrue.  A BQM must respond to current understanding of benefits. To this end, 
articulations of “benefits” were studied in government policy and the practice of recent 
NHSScotland projects. Required BQM functionality was inferred from these insights and is 
discussed below. 
2.2	 Benefits in Government Policy
Policy definitions of project success are provided by the HM Treasury “Green Book” which 
distinguishes “outcomes” from “outputs.” Outcomes are “the eventual benefits to society that 
proposals are intended to achieve.” Outcomes can “sometimes cannot be directly 
measured” (HM Treasury, 2003, p. 13), requiring outputs (such as buildings) to indicate their 
delivery. HM Treasury (ibid.) defines four benefit types: financial quantitative; non-financial 
quantitative; non-financial qualitative; and outcomes. “Improved standards of healthcare” are 
cited as an example of outcomes (ibid., p. 44). Guidance thus establishes that investments can 
realise intangible benefits that are evidenced by outputs such as buildings. The Scottish Capital 
Investment Manual (SCIM) Business Case Guide (Scottish Government, 2009a, p. 25) associates 
programmes with outcomes and, specifically, benefits, while associating projects with outputs 
such as “buildings.” Thus, Scottish Government policy contradicts the Treasury’s association of 
benefits with projects.
2.3	 Benefits in Healthcare Infrastructure Investment Policy 
Realisation of “benefits” from infrastructure investments is treated variously by the guidance of 
HM Treasury; the Office of Government Commerce; the Department of Health; and, in Scotland, 
Scottish Government. Governing mid-value projects, ProCure21 makes little mention of benefits, 
only requiring a “benefits realisation plan” in Full Business Case (FBC) submissions (Department 
of Health, 2007). Frameworks Scotland guidance also requires FBCs to include such a plan 
(Health Facilities Scotland, 2008) but no other consideration of benefits.  Negligible healthcare-
specific benefit realisation guidance is available to healthcare providers. Instead, the need to 
realise benefits is inherited by from central government guidance and policy. This may be 
problematic as generic central government requirements do not always translate into healthcare. 
2.4 Benefits in Healthcare Providers’ Infrastructure Investment Practice
Desktop survey reviewed the application of benefit-related guidance to healthcare projects. The 
study reviewed current practice; the role of guidance in shaping it; and practices that require 
improvement. The survey sought to determine if components of a BRMP are present in current 
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practice and if benefits are quantified appropriately. The study reviewed submissions to each 
stage of the SCIM gateway process (Fig. 1) to determine how benefits are articulated at all formal 
stages of investment progression. The nomenclature identifying each case below is presented in 
the Appendix.  
Fig. 1. Relationship of Business Case Submission to Capital Value and Gateway Review, 
adapted from Scottish Government (2009a)
2.4.1	 Treatment of Benefits in Initial Agreements
Initial Agreements (IAs) bridge the healthcare provider’s investment programme with the projects 
that advance programme strategy. The purpose of an IA is “firstly to establish the case for 
change and the need for investment; and secondly, to provide a suggested way forward for the 
scheme for the early approval of management” (Scottish Government, 2009b). An IA is typically 
the healthcare provider’s first formalisation of a project and, as such, those reviewed were found 
to place notional importance on benefits.
Benefits were observed to be mentioned in passing; related contextually to the programme 
outcomes of which the project’s outputs will provide evidence.  Several NHS Boards exhibited 
awareness of the need to provide “proposed outcomes” but, by the terminology used, perceived 
these as related to the investment programme rather than the project that the IA justifies. These 
observations suggest that current practice does not provide sufficiently well-developed 
understanding of benefits to guide investment management at this embryonic project stage.
IA.5 and IA.7 included a “benefits realisation plan.” These re-stated benefits along with 
‘indicators’ (e.g. “Increase in number of referrals” to indicate the benefit of “To provide a choice of 
birth centre for women at low risk” (IA.5)), timescales for delivery and responsible individuals. 
These plans were accordingly interpreted as an attempt to construct the “benefits profiles” 
required by OGC (undated, a).
2.4.2	 Treatment of Benefits in Standard Business Cases
As Standard Business Cases “do not have to be submitted to SGHD for approval but may be 
requested for information purposes” (SGHD, undated), guidance on their content is lacking. The 
SBCs studied exhibited moderate awareness of the need to provide benefits, which were 
described as “proposed outcomes - benefits to patients” (SBC.1) or “proposed outcomes and 
benefits to clients” (SBC.2), again suggesting conceptual links to their originating programme and 
sought investment outcomes. 
4
Two extremes of benefits articulation were observed: a verbose form without the specificity 
required by a BRMP; and a terse form too ambiguous for BRMP application. SBC.1 verbosely 
described its sought outcomes (e.g. “Dedicated facilities for teenagers will be provided with 
separate rooms for teenagers, and a separate relaxation area, which will help bridge the gap with 
the inappropriate placement of teenagers in adult or children’s wards.”), while SBC.2 provided 
terse descriptions (i.e. “clinical effectiveness; access; flexibility; comprehensiveness; impact; 
appropriateness”). 
2.4.3	 Treatment of Benefits in Outline Business Cases
Projects of capital value above £5m prepare an Outline Business Case (OBC). All observed OBCs 
complied with the SCIM Business Case Guide (Scottish Government, 2009b) required for 
“benefits appraisal” to select a preferred option by comparing potential benefits with capital 
costs. In recognising that “some benefits are not amenable to monetary values” the SCIM 
requires “non-financial benefits” to be weighted and scored (see Scottish Government, 2009c, pp. 
119-120 for an illustration). However, the observed OBCs treated all benefits in this way. Further, 
and more significantly, rather than further understanding benefits established by the IA, most 
OBCs introduced a new set of benefits described as “benefit criteria.” OBC.4 defined these criteria 
as “non-financial benefits that could be gained from redesign of current services.”
Table 1: Classification of Observed Benefit Criteria
Benefit criteria were typically introduced by a “project board” comprising patient, manager, and 
clinician stakeholder representatives (OBC.1); stakeholders themselves (OBC.4); or an undefined 
“project group” (OBC.6). This practice created the potential for the selected option to address a 
set of benefits distinct from those justifying the project in its IA. Given the relationship of project 
outputs to programme outcomes and the need for alignment between them, continuity of 
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understanding of project-specific benefits should be sustained through the programme strategy, 
its implementation via projects, and the progression of those projects. The introduction of newly-
defined benefit criteria potentially disrupts this continuity. It creates the risk of considering 
benefits that are not aligned with programme strategy.
The observed benefit criteria were remarkably similar in all OBCs (Table 1). The generic nature of 
benefit criteria inserted at OBC stage suggests that option appraisal must represent a value 
system common to all healthcare investments. Whether these values are the result of 
overarching government policy, the professional values of healthcare providers, or an innate 
societal understanding of what is ‘appropriate’ for healthcare provision is beyond the scope of 
this study. This observation does, however, establish investment option viability is being 
evaluated against generic benefits, rather than the project-specific benefits required by policy. 
This practice is potentially harmful as it divorces programme intent from project action. 
2.4.4	 Treatment of Benefits in Full Business Cases
Full Business Cases (FBCs) are required for all projects requiring a capital investment over £5m. 
The FBCs reviewed both contained benefits realisation plans, as required by guidance.  These 
plans translated the objectives of the instigating investment programme into project level 
benefits (albeit expressed with varying terminology) to provide alignment. As above, the 
progressive definition of benefits through project delivery was not observed, creating the 
potential for interpretation of programme objectives to define benefits at FBC that contradict 
those defined in preceding IA and OBC gateways.
The benefits defined were somewhat generic in nature, although this is arguably a consequence 
of the scale of the FBC investments (FBC.3 and FBC.4, for example, address a c. £300m acute 
hospital). The practice of disaggregating benefits into a series of more-specific benefits to 
provide clarity was observed.  FBC.1 disaggregated six benefits (termed “objectives”) into an 
average of four or five sub-benefits each.  FBC.3 split four benefits (termed “services”) into c. five 
sub-benefits each.  This disaggregation activity has significant consequence for the development 
of a BQM, as discussed below. 
2.5	 Implications of Observations for Benefits Realisation Practice
The desktop survey concluded that benefits, in practice, are treated variously. Understanding and 
practice varies between NHS Boards due to multiple guidance sources, each of which articulates 
‘benefits’ differently. A tendency towards overly-operationalised treatment of benefits was 
observed. A focus on implementing a process rather than ensuring the process was appropriate 
was noted. Such approaches were typified by the use of proxy metrics (such as assessing 
patient satisfaction by the number of complaints received, cf. OBC.7) to implement a standard 
process, without questioning the ability of that process to realise benefits effectively.  
Practice generally made a fair attempt at following guidance, aside for the introduction of benefit 
criteria in OBCs. While the procedures used to generate benefit criteria can be construed to 
comply with current guidance, the question of why the elicitation processes always yield a similar 
set of effectively-generic criteria from project-specific stakeholder groups must be raised. 
Facilitator and non-response bias are issues of concern. 
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Current benefits delivery practice can be characterised as confused and conflicted. Some traits 
of a BRMP were observed, namely: the provision of Benefits Realisation Plans (albeit limited in 
scope) in FBCs; and the inclusion of functional-equivalents of Benefits Profiles in some cases. In 
the absence of an explicit and coherent BRMP, however, bespoke practice often failed to define 
benefits in ways that allow their realisation to be clearly demonstrated. Indeed, there is no 
evidence that anticipations of benefits realisation supporting gateway approvals are revisited 
later to confirm their accuracy. There is a clear need for a healthcare-specific BRMP to define 
best practice and for an associated BQM to characterise benefits realisation at key stages in the 
investment process. 
2.6	 The Need to Disaggregate Benefits
An observation of particular note is the emergent practice in some cases (OBC.2; OBC.9; FBC.1; 
FBC.2) of ‘disaggregating’ otherwise amorphous or ambiguous definitions of benefits to provide 
clarity. As this practice is emergent, it is not yet codified by guidance and, as such, is performed 
variously. OBC.2, for example disaggregated the amorphous “inpatient and ambulatory care 
services” benefit into nine sub-benefits, two of which related to the provision of buildings, four to 
healthcare service provision, and three to NHS Board operation. FBC.1, in contrast, disaggregated 
a generic benefit of “improved clinical effectiveness” into five sub-benefits each of which was 
described verbosely (e.g. “Development of more GPs with Special Interest to deliver services 
more locally”) and none of which could be clearly associated with buildings, services, or board 
operation. 
As it has emerged independently in different NHS Boards and in different forms of business case, 
it is concluded that the practice of disaggregating benefits into a series of sub-benefit 
components, albeit in part caused by the absence of BRMP-derived benefits definition guidance, 
is proving useful. Engaging stakeholders in benefits definition would build common 
understanding and increase consistency of subsequent evaluations. Further, the disaggregation 
process would provide an opportunity to associate qualities of the emerging service or asset with 
the benefit whose provision they represent. As these qualities could be experienced or observed 
by stakeholders, judgements of their magnitude could usefully indicate the extent of realisation 
and perceived worth of their associated benefit. This emergent practice was clearly helpful. 
3. 	 Foundations of a Benefits Quantification Method 
The above has established the nature of benefits as currently conceived by Scottish investors in 
healthcare services and infrastructure. This section suggests four functions that a Benefits 
Quantification Method (BQM) must perform in light of current understanding of the need to 
inform a BRMP. 
3.1	  Principle 1: 	 Articulation of benefits
Because stakeholders embark on projects to improve their situation, the benefits sought are 
‘desired outcomes.’ A BQM must adopt stakeholders’ perceptions of benefit as the most 
meaningful measure of their realisation. 
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3.2 Principle 2:  Representing tangible and intangible benefits 
   in measurable terms
Benefits must be broken down into the benefit generating qualities that stakeholders collectively 
associate with them and would accept as evidence of their realisation. Benefit disaggregation 
methods must establish the evidence that demonstrates benefits realisation. 
3.3  Principle 3:  Translating benefit provision magnitude into 
   benefit realisation worth
The diminishing marginal utility associated with increasing magnitudes of good or service 
provision must be acknowledged. An intermediate step is required to elicit the utility function that 
translates stakeholders’ judgement of benefit generating qualities provided by investment 
outputs into the perception of its benefit. These perceptions of worth (rather than magnitude) 
must indicate benefit realisation.  
3.4 	 Principle 4: 	 Reliably ascribing worth to benefit provision
A BQM must elicit stakeholder perceptions of benefit worth using carefully designed elicitation 
processes to overcome the many biases in stakeholder judgements. Anchoring bias, in particular, 
must be controlled by using project-specific comparator projects to frame judgement. 
4.	 Characterising the Magnitude of Benefit Realisation
The observation of benefit realisation requires a concept to parallel consumption so that the 
magnitude of each benefit’s realisation can be expressed. The provision of benefits from 
healthcare service provision is related to, and constrained by, properties of supporting 
infrastructure (such as buildings). 
Reflective design and learning processes make stakeholders’ understanding of the relationships 
between services and supporting infrastructure explicit, allowing it to be formalised and 
captured. This stimulates the double loop learning (Schön, 1983) by which initial conceptions of 
what a benefit would ‘look like’ when realised can be challenged by cycles of monitoring, 
mapping and observation (Fried, 2010). Evaluating the magnitude of benefit realisation among a 
group of stakeholders can, in itself, socially construct the common understanding required for a 
satisficing (Simon, 1969) investment output. The BQM will provide a two-stage process, wherein 
the physical or functional (note: not financial) qualities of infrastructure – defined as ‘Benefit 
Generating Qualities” (BGQs) – are elicited from stakeholders during project initialisation and 
then judged by them during project delivery. 
The desktop survey confirmed the appropriateness of disaggregating benefits into their 
constituent BGQs. This emergent practice was observed in FBC.1 wherein each of the “benefits 
to patients” required from the chosen option was disaggregated into several desired qualities of 
the investment output (Table 2). Such qualities can be interpreted as benefit generating qualities. 
Disaggregation of the benefit into a series of BGQs unpacks the understanding assigned to that 
benefit by a group of stakeholders in a specific situation. The BGQs associated with a benefit on 
one project could not be transposed to another project as a benefit that superficially appears the 
same (i.e. has the same description) would be ascribed a different meaning by different 
stakeholders. 
8
Table 2. Example Disaggregation of an Example “Benefit to Patients” into 
The BGQ process is justified by two conceptual links to existing practice. First, it reflects HM 
Treasury Green Book policy which states that investment outputs can be considered evidence of 
the benefits sought as investment outcomes. Second, it considers qualities as attributes of the 
artefact resulting from the investment. It is access to these qualities that stakeholders seek 
rather than, beyond symbolism, the artefact itself. Some BGQs will be qualities of the artefact (i.e. 
building features) and others of the healthcare service it accommodates.  
5.	 Characterising the Worth of Benefit Realisation
5.1	 Selecting an Appropriate Benefit Valuation Technique
Goods and tangible services can be traded. This allows their value to be derived from 
stakeholders’ ‘revealed preferences’ (Pearce and Özdemiroglu, 2002) in open market function: the 
benefits of these goods or services are worth the price that individuals will pay for them. HM 
Treasury (2003) also requires all the “non-market impacts” of investment programmes to be 
valued. The healthcare service public good, and the buildings facilitating same, typify such 
impacts. As the intangible benefits associated with same cannot be readily traded, ‘stated 
preference’ valuation methods must ask stakeholders about the value of such commodities. 
The Green Book (HM Treasury, 2003, p. 57) recommends Willingness to Pay (WTP) as the 
“preferred method of valuation to simulate the market” when valuing non-market goods and 
services. WTP and the related Contingent Valuation (CV) can elicit stakeholder judgements of all 
types of healthcare investment benefit using carefully designed methods to accurately determine 
what stakeholders would pay for these public goods if they could be traded. However, despite 
their endorsement by the Treasury, stated preference valuation methods remain inherently weak 
because, as van Exel et al. (2006) note, “‘saying’ and ‘doing’ may differ.” 
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5.2	 Translation Principles
Benefits realisation in practice requires the benefit ‘worth’ (i.e. the amount that stakeholders 
would pay for it) to be determined. This worth can be expressed in monetary terms, although any 
other notional unit of consistent scale over time can be used. By relating this unit to levels of 
benefit magnitude by means of ‘comparator’ project outputs, the BQM will assist stakeholders in 
socially constructing a common understanding of benefit worth. Provided that the worth unit is 
commonly understood, it can translate an observed magnitude of BGQ provision into a common 
understanding of the worth of the benefit they generate. Integrating worth and magnitude into a 
function permits assessment of marginal changes in worth. This is achieved by an adaptation of 
a utility function that the BQM calls a benefit function.
Utility theory models the relationship between the amount of a good or service consumed or 
experienced and the resulting perception of utility. When applied to benefits quantification, utility 
theory allows the observed magnitude of BGQs to be related to the benefit arising from them, as 
judged by each stakeholder. The utility function that performs this translation of infrastructure 
qualities into benefit worth allows the many inputs to the function (and broader influences on the 
positioning judgement) to be taken into account. This is illustrated by Fig. 2. Assume that points 
a, b and c are equidistant. An increase in the magnitude of provided infrastructure or service 
qualities (i.e. an increase in quality) generates a larger increase in stakeholders’ perceptions of 
benefit worth when moving from point a to b than from point b to c. At a certain point, additional 
increases in BGQ provision would not be worthwhile due to diminishing marginal increases in 
perceived benefit worth. Monotonic benefit functions such as this can inform the selection of an 
optimum provision of each benefit. 
 
Fig. 2. Example of a Monotonic Benefit Function Exhibiting Typical StakeholderPerceptions of 
Diminishing Marginal Benefit Worth with Increases in BGQ Magnitude
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The eliciting of benefit functions is difficult. As the UK National Health Service is a public good, 
the majority of UK residents do not directly pay for its services. This can cause consumers to 
consider that healthcare and, therefore, healthcare benefits have no intrinsic ‘worth.’ This 
problem is also faced when valuing environmental goods and services. There are generally no 
means of ascertaining exactly who benefits from such assets, or the manner or degree to which 
they benefit (Smith et al., 1999).  Environmental non-market goods have a value to society, but 
their worth is unknown (Cookson, 1998).  ‘Willingness to Pay’ is a stated valuation technique that 
has proven particularly effective at evaluating the worth of these intangible goods.  Evidence of 
its insightfulness in the healthcare sector is also present.  
5.3	 Willingness to Pay
Willingness to Pay (WTP) is a stated preference valuation technique ideally suited to eliciting 
stakeholders’ judgements of benefits worth.  The technique is applicable to intangible benefits 
and public goods; is proven in healthcare; and is reasonably reliable, provided certain biases are 
controlled. It can be readily operationalised to inform gateway reviews, design reviews, and so 
forth.  
WTP is a representation of “total economic value” (Samuelson, 1954).  That is, a stakeholder’s 
statement of their willingness to pay captures their perceptions of their change in their human 
wellbeing that will arise as a consequence of a variation in benefit magnitude (ibid.).  The 
expressions of benefit worth elicited by WTP as operationalised in the BQM arise as a 
consequence of stakeholders’ perceptions of the change in their wellbeing arising from the 
project. 
The BQM uses WTP to ask individual stakeholders the amount of a notional ‘currency of worth’ 
that they would sacrifice to preserve or gain a level of (tangible or intangible) good or service or, 
alternatively, how much they would accept as compensation for its loss or reduction. WTP 
techniques thus create a proxy market in which varying magnitudes of benefit provision are 
evaluated, assuming that an individual’s stated shadow prices (Pearce, Özdemiroglu, et al., 2002) 
are related to their preferences (Mourato, 1998). 
The ability of WTP to evaluate intangible benefits is proven by widespread use of its techniques 
to value environmental public goods (e.g. Ahlheim, 1998; Hanley et al., 2003), where it is often 
implemented using contingent valuation (DEFRA, 2007; Schläpfer, 2008), and infrastructure 
improvements (McFadden, 1997; Pearce, Özdemiroglu, et al., 2002; Andersson et al., 2009).  
Further, precedent for using WTP to evaluate immaterial healthcare goods and services exists, 
including: short term outcomes in heart surgery patients (Greenberg et al., 2004); the non-health 
benefits of health programmes (Borghi and Jan, 2008); pain reduction and pain-related disability 
(Anderson et al., 2007); and demand for healthcare (Gyldmark and Morrison, 2001). In healthcare, 
WTP helps stakeholders consider “the entire range of attributes [read: benefit generating 
qualities] (both benefits and non-benefits)” of the good or service (Blumenschien and 
Johannesson, 1999).  In group settings, WTP can specifically stimulate the “stakeholder 
dialogue” (Cass, 2006) required to deliberate and negotiate group valuations.  
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WTP is not without problems, however. WTP is vulnerable to hypothetical bias, as stakeholders 
find it difficult to reliably evaluate unfamiliar goods unless the choice context provides reliable 
cues to help the stakeholder create heuristics for their valuation (Schläpfer, 2008). Pearce, 
Özdemiroglu, et al. (2002) consider all stated preference valuation techniques “costly and time 
consuming.” “Benefits transfer,” where the results of prior WTP evaluations are transferred 
directly into later ones or averaged over several evaluations to provide a “meta-analysis,” can 
overcome this. Its appropriateness to healthcare infrastructure investments, where sought 
benefits are project-specific and stakeholder composition differs between projects is unlikely. 
WTP biases have been detected in some studies, and disproven in others, indicating that WTP 
design critically influences results validity. The choice of payment vehicle, evaluation question 
framing, payment vector, and mode of delivery all require careful consideration. WTP applications 
control for inherent judgement biases. Comparator projects or benefit delivery scenarios must be 
defined to frame stakeholders’ evaluations by providing implied value cues (Blumenschein and 
Johannesson, 1999) that control for anchoring bias which, along with availability and 
representativeness biases, is implicit in all cognitive judgement (Browne and Ramesh, 2002). 
Although the single-choice WTP technique can be readily operationalised into the workshop 
settings of a BRMP, WTP remains particularly sensitive to anchoring bias in such “referendum” 
settings (Green et al., 1998).  The BQM will control this bias using comparator projects to provide 
dimension and units to the judgement scale on which the magnitude of BGQ presence is 
perceived.   
6.	 Discussion and Future Direction 
By identifying diversity of benefits and inconsistencies in their definition methods the desktop 
study has demonstrated the need for a unified approach to benefits management. A BQM 
associated with a BRMP has been outlined to characterise investment performance in realising 
sought benefits. Linking the concepts of infrastructure provision, resulting benefits, and 
stakeholder perceptions of worth through the use of benefits functions, the BQM will tackle a 
range of management issues: stakeholder engagement and consultation; improved 
communication of benefits in the business case; and ongoing monitoring of benefit realisation 
throughout project life. A BQM and BRMP developed to achieve this will inform the management 
of technically complex projects which lack financial (or otherwise directly measurable) success 
criteria and involve a diversity of stakeholders with varying and often conflicting expectations. 
Having characterised the benefits realisation problem, the underlying study is now establishing 
the BQM processes. Stated preference methodologies are being adapted to determine 
stakeholder perceptions of worth and, at the time of writing, workshop sessions are testing 
elicitation, anchoring and framing techniques to implement BQM stages (Table 3). Possible 
methods are being tested with several NHSScotland Boards and professional consultants to 
establish their insight and ability to be operationalised into a workable tool. 
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Table 3. Preliminary Definition of BQM Stages
In addition to informing a BRMP, the BQM can inform specific investment decisions, most notably 
option appraisal conducted at Outline Business Case.  Irrespective of whether health service 
provision (Scottish Health Council, 2010) or capital investment (Scottish Government, 2009c) 
options are being evaluated, ‘non-monetary costs and benefits’ must be “weighted and scored.”  
The review of the OBCs presented determined that this policy is seldom implemented. When 
attempts to comply with policy are made, superficial judgements (e.g. marks out of ten, or 
percentages) are arbitrarily assigned to benefits. Rigour, auditability and defendable stakeholder 
engagement are not present. Using the BQM to quantify benefit realisation will address this 
significant shortcoming. 
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Appendix: 	 Index of Business Cases Informing Desktop Survey
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